{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "63824-744",
      "generic_name": "BENZOCAINE and DEXTROMETHORPHAN HYDROBROMIDE",
      "labeler_name": "Reckitt Benckiser LLC",
      "brand_name": "Cepacol Extra Strength Sore Throat and Cough",
      "brand_name_suffix": "Extra Strength Sore Throat and Cough",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "5 mg/1"
        },
        {
          "name": "BENZOCAINE",
          "strength": "7.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "63824-744-16",
          "description": "2 BLISTER PACK in 1 CARTON (63824-744-16)  / 8 LOZENGE in 1 BLISTER PACK",
          "marketing_start_date": "20140505",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Reckitt Benckiser LLC"
        ],
        "rxcui": [
          "1039251",
          "1039255"
        ],
        "spl_set_id": [
          "c0cc32db-90f0-4106-8538-89821083ece1"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0363824740164"
        ],
        "nui": [
          "N0000185508",
          "N0000175629",
          "N0000184306",
          "M0000728"
        ],
        "pharm_class_epc": [
          "Standardized Chemical Allergen [EPC]"
        ],
        "pharm_class_pe": [
          "Increased Histamine Release [PE]",
          "Cell-mediated Immunity [PE]"
        ],
        "pharm_class_cs": [
          "Allergens [CS]"
        ],
        "unii": [
          "9D2RTI9KYH",
          "U3RSY48JW5"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "LOZENGE",
      "spl_id": "51b5d087-def6-54b3-e063-6294a90ac9ad",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20140505",
      "product_id": "63824-744_51b5d087-def6-54b3-e063-6294a90ac9ad",
      "application_number": "M012",
      "brand_name_base": "Cepacol",
      "pharm_class": [
        "Allergens [CS]",
        "Cell-mediated Immunity [PE]",
        "Increased Histamine Release [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Standardized Chemical Allergen [EPC]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}